7CJW

Solution structure of monomeric superoxide dismutase 1 with an additional mutation H46W in a crowded environment

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-15N NOESY	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
2	3D 1H-13C NOESY aliphatic	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
3	3D 1H-13C NOESY aromatic	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
4	2D 1H-15N HSQC	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
5	2D 1H-13C HSQC aliphatic	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
21	2D 1H-13C HSQC aromatic	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
20	3D HNCO	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
19	3D HN(CA)CO	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
18	3D HNCA	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
17	3D HN(CO)CA	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
16	3D CBCA(CO)NH	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
15	3D HNCACB	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
14	3D CC(CO)NH	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
13	3D HCCH-COSY	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
12	3D HCCH-TOCSY	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
11	3D H(CCO)NH	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
10	2D (HB)CB(CGCD)HD	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700
9	2D (HB)CB(CGCDCE)HE	1 mM [U-13C; U-15N] Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, with an additional mutation H46W, 10 mM Bis-Tris, 50 mg/mL Lysozyme from Egg White	95% H2O/5% D2O	0 mM	6.3	1 atm	298	Bruker AVANCE II 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE II	700

NMR Refinement
Method	Details	Software
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	3.98.5	Guntert, Mumenthaler and Wuthrich
2	processing	NMRPipe	9.6	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	structure calculation	TALOS		Cornilescu, Delaglio and Bax
4	data analysis	CcpNmr Analysis	2.4.2	CCPN
5	refinement	MOLMOL	2K.2	Koradi, Billeter and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.